B
Bio-Works Technologies AB
STO:BIOWKS
Bio-Works Technologies AB
STO:BIOWKS
Price:
3.21
SEK
5.25%
Market Closed
Market Cap:
kr250.3m
Relative Value
There is not enough data to reliably calculate the relative value of BIOWKS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIOWKS
Relative Value
Base Case
Not Available
Multiples Across Competitors
BIOWKS Competitors Multiples
Bio-Works Technologies AB Competitors
Bio-Works Technologies AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
B
|
Bio-Works Technologies AB
STO:BIOWKS
|
250.3m SEK | 5.7 | -4.4 | -3.8 | -3.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.5T JPY | 10.4 | 38 | 27.5 | 33 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.4B CHF | 3.6 | 38.5 | 14.8 | 28.8 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
100.6B DKK | 3.6 | 25.4 | 13.3 | 15.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.3B USD | 3.1 | 30 | 12.9 | 17.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 2.5 | 34.6 | 12 | 18.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.7 | 16.9 | 54.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.6B CNY | 8.9 | 24.5 | 22.1 | 22.1 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
40.3B CNY | 4.1 | 23.7 | 35.5 | 35.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
828.9B JPY | 6.4 | 46.9 | 22.1 | 30 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
